Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 18;325(19):2015-2016.
doi: 10.1001/jama.2021.5612.

Symptoms and Functional Impairment Assessed 8 Months After Mild COVID-19 Among Health Care Workers

Sebastian Havervall  1 , Axel Rosell  1 , Mia Phillipson  2 , Sara M Mangsbo  2 , Peter Nilsson  3 , Sophia Hober  3 , Charlotte Thålin  1
Affiliations

Symptoms and Functional Impairment Assessed 8 Months After Mild COVID-19 Among Health Care Workers

Sebastian Havervall et al. JAMA. .

Erratum in

  • Error in Affiliations.
    [No authors listed] [No authors listed] JAMA. 2025 May 20;333(19):1733. doi: 10.1001/jama.2025.5904. JAMA. 2025. PMID: 40267507 Free PMC article. No abstract available.

Abstract

This cohort study describes COVID-19–related symptoms persisting 8 months after SARS-CoV-2 infection among Swedish health care workers and self-reported effects of the residual symptoms on respondents’ home, work, and social function.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Mangsbo reported being a chief innovation officer for Ultimovacs and being a founder and board member for Immuneed and Strike Pharmaceuticals outside the submitted work. No other disclosures were reported.

Figures

Figure.
Figure.. COVID-19–Related Long-term Functional Impairment
The percentage of seropositive (n = 323) and seronegative (n = 1072) participants reporting symptoms lasting at least 2 months and their related functional impairment in their work, social, and home life using the Sheehan Disability Scale (1-3, mild; 4-6, moderate; and 7-10, marked).
See this image and copyright information in PMC

References

    1. Carfì A, Bernabei R, Landi F; Gemelli Against COVID-19 Post-Acute Care Study Group . Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603-605. doi:10.1001/jama.2020.12603 - DOI - PMC - PubMed
    1. Arnold DT, Hamilton FW, Milne A, et al. . Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax. Published online December 3, 2020. doi:10.1136/thoraxjnl-2020-216086 - DOI - PMC - PubMed
    1. Logue JK, Franko NM, McCulloch DJ, et al. . Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw Open. 2021;4(2):e210830. doi:10.1001/jamanetworkopen.2021.0830 - DOI - PMC - PubMed
    1. Sudre CH, Murray B, Varsavsky T, et al. . Attributes and predictors of long COVID. Nat Med. Published online March 10, 2021. doi:10.1038/s41591-021-01292-y - DOI - PMC - PubMed
    1. Rudberg AS, Havervall S, Månberg A, et al. . SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden. Nat Commun. 2020;11(1):5064. doi:10.1038/s41467-020-18848-0 - DOI - PMC - PubMed

Publication types

Substances